Written Question · S2W-15196 · Session 2
Whether NHS Quality Improvement Scotland will review drug prescribing guidance in relation to the treatment of Alhzheimer's disease.
The question
To ask the Scottish Executive whether NHS Quality Improvement Scotland will review drug prescribing guidance in relation to the treatment of Alhzheimer's disease.
The answer
The National Institute for ClinicalExcellence (NICE) has published an Appraisal Consultation Document entitled Alzheimer'sdisease
- donepezil, rivastigmine, galantamine and memantine. The consultation is openuntil 22 March 2005 and can be accessed at:
http://www.nice.org.uk/page.aspx?o=245912.
The consultation document doesnot constitute the Institute's formal guidance on these drugs and the recommendationmade is preliminary and may change after the consultation. A final recommendationwill be made later in the year. At that point, NHS Quality Improvement Scotlandwill provide advice on how relevant the guidance from NICE on these drugs is forNHSScotland.
- donepezil, rivastigmine, galantamine and memantine. The consultation is openuntil 22 March 2005 and can be accessed at:
http://www.nice.org.uk/page.aspx?o=245912.
The consultation document doesnot constitute the Institute's formal guidance on these drugs and the recommendationmade is preliminary and may change after the consultation. A final recommendationwill be made later in the year. At that point, NHS Quality Improvement Scotlandwill provide advice on how relevant the guidance from NICE on these drugs is forNHSScotland.
In the Official Report
No contribution in the Official Report cites S2W-15196 by reference.